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PEER REVIEWED
 
Maine licensed pharmacy locations, blood pressure medication adherence rates, and population density in 2018. Medication adherence in 2015 among Maine
adults aged 18 to 64, calculated for renin–angiotensin system antagonists by using the proportion-of-days-covered method, was 83.8% (95% confidence interval,
83.4%–84.1%). York County had the highest adherence rate (85.2%; 95% confidence interval, 84.3%–86.0%). Counties with medication adherence rates
significantly lower than the York County rate indicate where to focus interventions. Adult census tract–level population density for 2012 through 2016 indicates
where to implement rural-specific interventions.
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Background
Maps showing US state-level data help researchers understand the
geographic  distribution  of  chronic  disease  burden.  As  public
health analysts refine spatial analysis skills, sub-state analyses are
sought to determine how to tailor interventions to specific popula-
tions so that public health programs can use limited funds most ef-
fectively. A workgroup at the Division of Disease Prevention at
the  Maine  Center  for  Disease  Control  and  Prevention  (Maine
CDC) created this map to determine where and how to administer
public health programs among adults aged 18 to 64 to increase ad-
herence to antihypertensive medication regimens, ultimately influ-
encing hypertension control rates.
In 2015, one in 3 Maine adults (33.4%) had diagnosed hyperten-
sion  (1),  and  in  2015–2016  only  half  of  Americans  with  dia-
gnosed hypertension had controlled hypertension (2). Adherence
to antihypertensive medication is associated with controlled hyper-
tension and reduced risk of cardiovascular events (2). US costs for
hypertension without heart disease, including health care services,
medications, and missed work, totaled $55.9 billion in 2014–2015
dollars (3). Recent evidence also shows that adults aged 35 to 64
are less likely than adults aged 65 or older to take blood pressure
medication and have controlled hypertension, thereby increasing
their risk for heart disease and stroke (4). Reducing hypertension
and cardiovascular events are public health priorities and Healthy
People 2020 indicators (5). The Million Hearts program, a nation-
al initiative to prevent 1 million heart attacks and strokes, pro-
motes efforts to control hypertension through increasing medica-
tion adherence and self-measured blood pressure monitoring (6).
Because half of Maine’s land area is uninhabited and 40.8% of the
state population lives in rural counties, population density is a crit-
ical component in understanding rural health needs. Rural areas
tend to have more veterans, older adults (≥65 y), and residents liv-
ing in poverty than urban areas (7), and rural residents may face
unique challenges in controlling hypertension, such as living long
distances from pharmacies or physicians.
Data Sources and Map Logistics
Licensed pharmacy locations were received from the 2018 Maine
Department of Professional and Financial Regulation Database
and geocoded (8). Adult population density, representing adults
aged 18 to 64, was calculated from the 2012–2016 US Census
population estimates by dividing the total population of adults
aged 18 to 64 by the census tract land area (square miles) (9,10).
Five manual breaks were used to show variation in adult popula-
tion density.
 
Pharmacy  claims  from  the  2015  Maine  Heal th  Data
Organization’s All-Payer Claims Database (APCD), used to calcu-
late blood pressure medication adherence rates, represent claims
from  private  and  Medicaid  beneficiaries  (11).  Though  some
private beneficiaries aged 65 to 85 may be Medicare Part D bene-
ficiaries, not all Medicare Part D claims are included in the APCD.
Medication adherence was calculated according to Centers for
Disease  Control  and  Prevention  (CDC)  1305  grant  guidance,
which uses the proportion-of-days-covered method (having medic-
ation for ≥80% of total enrollment days) (12).
Because pharmacy claims could not be linked to medical claims in
the Maine APCD, we limited our analysis to renin–angiotensin
system antagonists (RASAs), which are used exclusively for hy-
pertension (RASA medications include angiotensin converting en-
zyme inhibitors, angiotensin II receptor blockers, and direct renin
inhibitors and are used only for hypertension, unlike other anti-
hypertensive medications). Total enrollment days were calculated
from the patient’s prescription start date through December 31,
2015 (12). Antihypertensive medication adherence was calculated
among Maine adults aged 18 to 85 who filed 2 or more prescrip-
tion claims for RASAs and had medication for at least 90 continu-
ous days in 2015. Medication adherence rates were calculated
among 2 age groups, 18 to 64 and 65 to 85, and Pearson χ2 tests (P
< .05)  were used to determine significance between the 2 age
groups. County rates among adults aged 18 to 64 were analyzed,
and a Pearson χ2 test (P < .05) was used to compare county-specif-
ic medication adherence rates to the Maine rate. Then, signific-
ance was determined by using a one-way ANOVA and least signi-
ficant differences test (P < .05), comparing the best county rate to
all other counties.
SAS version 9.4 (SAS Institute Inc) was used to calculate medica-
tion adherence rates and perform statistical analyses. No institu-
tional review board approval was required, but we completed a
data use agreement with the Maine Health Data Organization. The
map was produced in ArcGIS version 10.6 (Esri).
Highlights
Antihypertensive medication adherence rates increased with age
and were significantly lower among adults aged 18 to 64 (83.8%;
95% confidence interval [CI], 83.4%–84.1%) than among adults
aged 65 to 85 (86.9%; 95% CI, 86.6%–87.1%). Adherence rates
among adults  aged 18 to 64 were significantly higher in York
County (85.2%; 95% CI, 84.3%–86.0%) than in Maine overall
(83.8%; 95% CI, 83.4%–84.1%). Androscoggin, Franklin, Han-
cock, Kennebec, Knox, Penobscot, and Waldo counties had signi-
ficantly lower medication adherence rates (P < .05) than York
County, indicating where to tailor interventions (Table).
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Population density and pharmacy locations were concentrated in
southern coastal regions but varied substantially within counties
with lower medication adherence. Inset maps of Lewiston–Au-
burn (Androscoggin  County)  and Bangor  (Penobscot  County)
were included in the map accompanying this article to show great-
er detail for population-dense towns in counties with lower medic-
ation adherence rates. A limitation of the map is that medication
adherence rates may be slightly overestimated because of study in-
clusion criteria, the proportion-of-days-covered method, and re-
stricting analyses to RASAs only. The map does not display med-
ication adherence rates and is best used alongside data tables or an
internal interactive ArcGIS online web application that the Divi-
sion of Disease Prevention workgroup created.
Action
Maine CDC could use data presented in the map to focus future
tailored interventions in pharmacies located in counties with signi-
ficantly lower adherence rates and replicate successful practices in
York County pharmacies to improve medication adherence. Maine
CDC can help implement self-measured blood pressure monitor-
ing, lifestyle change programs, or telehealth interventions on the
basis of local population density. Self-measured blood pressure
monitoring and telehealth may be beneficial in areas with low pop-
ulation density because in-person lifestyle change programs may
be less effective if patients live far away from a retail pharmacy.
Applying all 3 approaches in densely populated areas could im-
prove medication adherence and hypertension control for a high
proportion of the state’s younger adult population (18–64 y). If the
interventions increased medication adherence in identified lower
adherence counties, 495 adults aged 18 to 64 taking RASA medic-
ations would be adherent to blood pressure medications, increas-
ing their chances of controlled hypertension. This conservative es-
timate was calculated by multiplying the difference between the
county rate and the York County rate (85.2%) by the county-level
study populations (Table) and summing the results. The Maine
CDC plans to replicate this collaborative map process to strategic-
ally inform other chronic disease prevention programs.
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Table
Table. Medication Adherence Among Adults Prescribed RASA Medications, by Demographic and Geographic Characteristics, Maine, 2015a
Characteristic No. (%)b % Adherentc (95% CI) P Valued
Total 105,663 (100) 85.5 (85.3–85.7) NA
Age, y
18–64 45,544 (43.1) 83.8 (83.4–84.1)
<.001
65–85 60,119 (56.9) 86.9 (86.6–87.1)
County, adults aged 18–64 y
Androscoggin 3,944 (8.7) 82.8 (81.6–84.0)
<.05e
Franklin 849 (1.9) 80.9 (78.3–83.6)
Hancock 1,581 (3.5) 82.2 (80.3–84.1)
Kennebec 4,366 (9.6) 82.8 (81.7–83.9)
Knox 1,142 (2.5) 81.6 (79.4–83.9)
Penobscot 5,829 (12.8) 83.4 (82.5–84.4)
Waldo 1,383 (3.0) 80.2 (78.1–82.3)
York 6,573 (14.4) 85.2 (84.3–86.0) —f
Abbreviations: CI, confidence interval; NA, not applicable; RASA, renin–angiotensin system antagonists.
a From Maine Health Data Organization, All Payer Claims Database (APCD) (11).
b Maine adults aged 18–85 recorded in APCD pharmacy claims who filled at least 2 prescriptions for RASA (renin–angiotensin system antagonists) medications in
2015 that totaled at least 90 continuous days’ supply, with the first prescription filled on or before September 30, 2015. Study population numbers may not sum
to group totals because of missing information on that demographic or geographic characteristic, and study population percentages may exceed 100% because of
rounding.
c Percentage of Maine adults aged 18 to 85 adherent to medication regimens (had medication for 80% of days from the patient’s prescription start date until the
end of the calendar year) based on 2015 Maine Department of Health APCD pharmacy claims.
d P values were calculated based on Pearson χ2 test at α = 0.05 between demographic groups.
e P values calculated by using the ANOVA test at α = 0.05 comparing York County to all Maine counties. Only significant counties were presented in this table.
f No P value was presented for York County because it is the county comparison rate.
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